Prestige Wealth Management Group LLC Biogen Inc. Transaction History

Prestige Wealth Management Group LLC

$465 Million
Q2 2025

A detailed history of Prestige Wealth Management Group LLC transactions in Biogen Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 38 shares of BIIB stock, worth $5,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 35 8.57%

Holding current value

$5,459

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$113.38 - $135.49 $340 - $406	3 Added 8.57%	38 $4,000
Q4 2024 Feb 11, 2025	SELL	$146.47 - $191.55 $585 - $766	-4 Reduced 10.26%	35 $5,000
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $2,646 - $3,315	-14 Reduced 26.42%	39 $7,000
Q2 2024 Aug 06, 2024	SELL	$190.52 - $236.72 $1,905 - $2,367	-10 Reduced 15.87%	53 $12,000
Q1 2024 Apr 26, 2024	SELL	$212.02 - $267.71 $636 - $803	-3 Reduced 4.55%	63 $13,000
Q4 2023 Apr 26, 2024	BUY	$222.59 - $267.94 $3,338 - $4,019	15 Added 29.41%	66 $17,000
Q4 2023 Feb 08, 2024	BUY	$222.59 - $267.94 $3,338 - $4,019	15 Added 29.41%	66 $17,000
Q3 2023 Apr 26, 2024	BUY	$253.3 - $285.89 $1,266 - $1,429	5 Added 10.87%	51 $13,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $1,266 - $1,429	5 Added 10.87%	51 $13,000
Q2 2023 Apr 26, 2024	BUY	$275.25 - $318.06 $3,853 - $4,452	14 Added 43.75%	46 $13,000
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $3,853 - $4,452	14 Added 43.75%	46 $13,000
Q1 2023 Apr 26, 2024	SELL	$256.56 - $292.34 $7,953 - $9,062	-31 Reduced 49.21%	32 $8,000
Q1 2023 May 16, 2023	SELL	$256.56 - $292.34 $1,282 - $1,461	-5 Reduced 13.51%	32 $8,000
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $252 - $306	-1 Reduced 2.63%	37 $10,000
Q3 2022 Nov 01, 2022	BUY	$194.69 - $268.46 $584 - $805	3 Added 8.57%	38 $10,000
Q1 2022 May 05, 2022	SELL	$193.77 - $244.14 $581 - $732	-3 Reduced 7.89%	35 $7,000
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $223 - $287	1 Added 2.7%	38 $9,000
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $4,403 - $7,050	-17 Reduced 31.48%	37 $13,000
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $242 - $284	-1 Reduced 1.82%	54 $15,000
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $7,087 - $10,668	30 Added 120.0%	55 $13,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $43,713 - $57,890	-169 Reduced 87.11%	25 $7,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $301,649 - $382,646	-1,122 Reduced 85.26%	194 $62,000
Q4 2019 Jan 28, 2020	SELL	$220.06 - $304.07 $3,520 - $4,865	-16 Reduced 1.2%	1,316 $390,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $10,872 - $12,194	-50 Reduced 3.62%	1,332 $310,000
Q2 2019 Aug 16, 2019	BUY	$219.29 - $241.72 $91,882 - $101,280	419 Added 43.51%	1,382 $323,000
Q1 2019 Aug 16, 2019	SELL	$216.71 - $338.96 $11,485 - $17,964	-53 Reduced 5.22%	963 $227,000
Q4 2018 Apr 16, 2019	BUY	$278.5 - $352.75 $282,956 - $358,394	1,016 New	1,016 $306,000

Others Institutions Holding BIIB

# of Institutions

1,021

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Biogen Inc. Transaction History